LGALS9B and Kaposi's sarcoma: The functional role of LGALS9B remains unclear in KSHV pathogenesis, however, previous work found interactions between the galectin-1 (Gal-1) and specific target N-glycans link tumor hypoxia to neovascularization as part of the pathogenesis of KS [48].